After Dr. Stephen Nelson’s retirement in early 2021, Children’s Minnesota is thrilled to announce that Derrick L. Goubeaux, DO, will step into the role of Sickle Cell Program Medical Director. Dr. Goubeaux joined the hematology oncology team at Children’s Minnesota in 2019. He leads a strong multidisciplinary team with specialized expertise in caring for the unique individual needs of this patient population. We are pleased that Dr. Goubeaux is leading our nationally recognized Sickle Cell program, which is responsible for treating the majority of children and teens in Minnesota with abnormal hemoglobins in addition to consulting about the disease with health care providers throughout the region.
Prior to coming to Children’s Minnesota, Dr. Goubeaux attended medical school at Nova Southeastern University and residency at Charleston Area Medical Center and West Virginia University. He then went on to complete his pediatric hematology oncology fellowship at Children’s Mercy Hospital in Kansas City, MO.
Dr. Goubeaux’s professional interests include hemoglobinopathies, bone marrow failure syndromes and quality improvement. In his personal life, he enjoys barbequing, and exploring the Twin Cities with his wife and two children.
Get to know Dr. Goubeaux
What advice do you like to give patients?
The goal for our patients is to ensure that sickle cell disease, while part of them, does not define them. In working together, we will be able to ensure they are able to live their lives to the fullest.
Who or what inspired you to become a clinician?
While I have had many tremendous mentors, I see Dr. Gerald Woods at Children’s Mercy Hospital as my biggest inspiration. He has spent his entire 30+ year career caring for patients with sickle cell disease. Watching him care for his patients with such respect, seeking compassion in all encounters, and the trust that his patients have in his guidance set the professional bar very high for me.
What keeps you passionate about your work?
Our amazing patients and families deserve a passionate, professional, dedicated team caring for them. Sickle cell disease has not received the attention and commitment it deserves from the health care community to provide equal, let alone equitable care. As providers and advocates for this population, it is our job to work to reverse this long-standing trend.
The team collaborates with professionals from across Children’s Minnesota to provide comprehensive care to patients, including dedicated social workers and child life specialists, and with clinicians in Children’s Minnesota pain and integrative medicine program.
Children’s Minnesota Sickle Cell program
Children’s Cancer and Blood Disorders program achieves outcomes that rank among the top national programs and cares for more than two-thirds of Minnesota children and adolescents with blood disorders. Care for sickle cell disease and hemoglobinopathies is provided through a division of the Cancer and Blood Disorders program called Children’s Hemoglobinopathy and Sickle Cell Program. Through this program, families have access to the newest and most promising treatments and receive care spearheaded and coordinated by a board-certified hematologist/oncologist.